Artificial Intelligence Assists Precision Medicine in Cancer Treatment

Overview

Journal Front Oncol

Specialty Oncology

Date 2023 Jan 23

PMID 36686757

Authors

Jinzhuang Liao

Xiaoying Li

Yu Gan

Shuangze Han

Pengfei Rong

Wei Wang

Wei Li

Li Zhou

Affiliations

Soon will be listed here.

Abstract

Cancer is a major medical problem worldwide. Due to its high heterogeneity, the use of the same drugs or surgical methods in patients with the same tumor may have different curative effects, leading to the need for more accurate treatment methods for tumors and personalized treatments for patients. The precise treatment of tumors is essential, which renders obtaining an in-depth understanding of the changes that tumors undergo urgent, including changes in their genes, proteins and cancer cell phenotypes, in order to develop targeted treatment strategies for patients. Artificial intelligence (AI) based on big data can extract the hidden patterns, important information, and corresponding knowledge behind the enormous amount of data. For example, the ML and deep learning of subsets of AI can be used to mine the deep-level information in genomics, transcriptomics, proteomics, radiomics, digital pathological images, and other data, which can make clinicians synthetically and comprehensively understand tumors. In addition, AI can find new biomarkers from data to assist tumor screening, detection, diagnosis, treatment and prognosis prediction, so as to providing the best treatment for individual patients and improving their clinical outcomes.

Citing Articles

Metabolic crossroads: unravelling immune cell dynamics in gastrointestinal cancer drug resistance.

Suri C, Pande B, Suhasini Sahithi L, Swarnkar S, Khelkar T, Verma H Cancer Drug Resist. 2025; 8:7.

PMID: 40051496 PMC: 11883236. DOI: 10.20517/cdr.2024.164.

Enhancing Treatment Decisions for Advanced Non-Small Cell Lung Cancer with Epidermal Growth Factor Receptor Mutations: A Reinforcement Learning Approach.

Bozcuk H, Sert L, Kaplan M, Tatli A, Karaca M, Muglu H Cancers (Basel). 2025; 17(2).

PMID: 39858018 PMC: 11763509. DOI: 10.3390/cancers17020233.

Integrating AI into Cancer Immunotherapy-A Narrative Review of Current Applications and Future Directions.

Olawade D, Clement David-Olawade A, Adereni T, Egbon E, Teke J, Boussios S Diseases. 2025; 13(1).

PMID: 39851488 PMC: 11764268. DOI: 10.3390/diseases13010024.

Predicting admission for fall-related injuries in older adults using artificial intelligence: A proof-of-concept study.

Le N, Sonka M, Skeete D, Romanowski K, Galet C Geriatr Gerontol Int. 2025; 25(2):232-242.

PMID: 39800578 PMC: 11788240. DOI: 10.1111/ggi.15066.

Machine learning-guided differential gene expression analysis identifies a highly-connected seven-gene cluster in triple-negative breast cancer.

Ghazal H, El-Absawy E, Ead W, Hasan M Biomedicine (Taipei). 2025; 14(4):15-35.

PMID: 39777114 PMC: 11703398. DOI: 10.37796/2211-8039.1467.

References

Bi W, Hosny A, Schabath M, Giger M, Birkbak N, Mehrtash A . Artificial intelligence in cancer imaging: Clinical challenges and applications. CA Cancer J Clin. 2019; 69(2):127-157. PMC: 6403009. DOI: 10.3322/caac.21552. View

Cheng S, Cheng Y, Jin Z, Xue H . Unresectable pancreatic ductal adenocarcinoma: Role of CT quantitative imaging biomarkers for predicting outcomes of patients treated with chemotherapy. Eur J Radiol. 2019; 113:188-197. DOI: 10.1016/j.ejrad.2019.02.009. View

Kaczmarek E, Pyman B, Nanayakkara J, Tuschl T, Tyryshkin K, Renwick N . Discriminating Neoplastic from Nonneoplastic Tissues Using an miRNA-Based Deep Cancer Classifier. Am J Pathol. 2021; 192(2):344-352. DOI: 10.1016/j.ajpath.2021.10.012. View

Hasin Y, Seldin M, Lusis A . Multi-omics approaches to disease. Genome Biol. 2017; 18(1):83. PMC: 5418815. DOI: 10.1186/s13059-017-1215-1. View

Takahashi S, Asada K, Takasawa K, Shimoyama R, Sakai A, Bolatkan A . Predicting Deep Learning Based Multi-Omics Parallel Integration Survival Subtypes in Lung Cancer Using Reverse Phase Protein Array Data. Biomolecules. 2020; 10(10). PMC: 7603376. DOI: 10.3390/biom10101460. View

Coudray N, Ocampo P, Sakellaropoulos T, Narula N, Snuderl M, Fenyo D . Classification and mutation prediction from non-small cell lung cancer histopathology images using deep learning. Nat Med. 2018; 24(10):1559-1567. PMC: 9847512. DOI: 10.1038/s41591-018-0177-5. View

Xie Y, Meng W, Li R, Wang Y, Qian X, Chan C . Early lung cancer diagnostic biomarker discovery by machine learning methods. Transl Oncol. 2020; 14(1):100907. PMC: 7683339. DOI: 10.1016/j.tranon.2020.100907. View

Wang T, Shao W, Huang Z, Tang H, Zhang J, Ding Z . MOGONET integrates multi-omics data using graph convolutional networks allowing patient classification and biomarker identification. Nat Commun. 2021; 12(1):3445. PMC: 8187432. DOI: 10.1038/s41467-021-23774-w. View

Berger M, Mardis E . The emerging clinical relevance of genomics in cancer medicine. Nat Rev Clin Oncol. 2018; 15(6):353-365. PMC: 6658089. DOI: 10.1038/s41571-018-0002-6. View

10.

Tomaszewski M, Latifi K, Boyer E, Palm R, El Naqa I, Moros E . Delta radiomics analysis of Magnetic Resonance guided radiotherapy imaging data can enable treatment response prediction in pancreatic cancer. Radiat Oncol. 2021; 16(1):237. PMC: 8672552. DOI: 10.1186/s13014-021-01957-5. View

11.

Huang G, Wang C, Fu X . Bidirectional deep neural networks to integrate RNA and DNA data for predicting outcome for patients with hepatocellular carcinoma. Future Oncol. 2021; 17(33):4481-4495. DOI: 10.2217/fon-2021-0659. View

12.

Gaublomme J, Li B, McCabe C, Knecht A, Yang Y, Drokhlyansky E . Nuclei multiplexing with barcoded antibodies for single-nucleus genomics. Nat Commun. 2019; 10(1):2907. PMC: 6606589. DOI: 10.1038/s41467-019-10756-2. View

13.

Schilling K, Landman B . AI in MRI: A case for grassroots deep learning. Magn Reson Imaging. 2019; 64:1-3. PMC: 8278255. DOI: 10.1016/j.mri.2019.07.004. View

14.

Zahoor M, Qureshi S, Bibi S, Khan S, Khan A, Ghafoor U . A New Deep Hybrid Boosted and Ensemble Learning-Based Brain Tumor Analysis Using MRI. Sensors (Basel). 2022; 22(7). PMC: 9002515. DOI: 10.3390/s22072726. View

15.

Wang K, Qiao Z, Zhao X, Li X, Wang X, Wu T . Individualized discrimination of tumor recurrence from radiation necrosis in glioma patients using an integrated radiomics-based model. Eur J Nucl Med Mol Imaging. 2019; 47(6):1400-1411. PMC: 7188738. DOI: 10.1007/s00259-019-04604-0. View

16.

Macosko E, Basu A, Satija R, Nemesh J, Shekhar K, Goldman M . Highly Parallel Genome-wide Expression Profiling of Individual Cells Using Nanoliter Droplets. Cell. 2015; 161(5):1202-1214. PMC: 4481139. DOI: 10.1016/j.cell.2015.05.002. View

17.

Johnson B, Creason A, Stommel J, Keck J, Parmar S, Betts C . An omic and multidimensional spatial atlas from serial biopsies of an evolving metastatic breast cancer. Cell Rep Med. 2022; 3(2):100525. PMC: 8861971. DOI: 10.1016/j.xcrm.2022.100525. View

18.

Hatzikirou H . Combining dynamic modeling with machine learning can be the key for the integration of mathematical and clinical oncology: Comment on "Improving cancer treatments via dynamical biophysical models" by M. Kuznetsov, J. Clairambault, V. Volpert. Phys Life Rev. 2022; 40:1-2. DOI: 10.1016/j.plrev.2022.01.002. View

19.

Lui T, Guo C, Leung W . Accuracy of artificial intelligence on histology prediction and detection of colorectal polyps: a systematic review and meta-analysis. Gastrointest Endosc. 2020; 92(1):11-22.e6. DOI: 10.1016/j.gie.2020.02.033. View

20.

Malone E, Oliva M, Sabatini P, Stockley T, Siu L . Molecular profiling for precision cancer therapies. Genome Med. 2020; 12(1):8. PMC: 6961404. DOI: 10.1186/s13073-019-0703-1. View